Is further screening of men with baseline PSA < 1 ng ml−1 worthwhile? The discussion continues—Results of the Swiss ERSPC (Aarau)

Is further screening of men with baseline PSA < 1 ng ml−1 worthwhile? The discussion continues—Results of the Swiss ERSPC (Aarau)

Recent studies indicate frequent early PSA retesting unrelated of men's baseline PSA, which increases the harms of early detection especially among men with low PSA. The current study investigates the PCa incidence among men with baseline PSA

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 2015-08, Vol.137 (3), p.553-559
Hauptverfasser: Randazzo, Marco, Beatrice, Josef, Huber, Andreas, Grobholz, Rainer, Manka, Lukas, Chun, Felix K., Kluth, Luis A., Wyler, Stephen F., Recker, Franz, Kwiatkowski, Maciej
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
Medical research
Medical screening
Prostate cancer
prostate specific antigen
PSA below 1
screening interval
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Recent studies indicate frequent early PSA retesting unrelated of men's baseline PSA, which increases the harms of early detection especially among men with low PSA. The current study investigates the PCa incidence among men with baseline PSA
ISSN:0020-7136
1097-0215
DOI:10.1002/ijc.29420